Literature DB >> 12783418

Endothelial dysfunction precedes C-fiber abnormalities in primary (AL) amyloidosis.

Martin Berghoff1, Madeera Kathpal, Faisal Khan, Martha Skinner, Rodney Falk, Roy Freeman.   

Abstract

Primary (AL; immunoglobulin light-chain associated) amyloidosis is characterized by the deposition of pathological proteins in the extracellular matrix of tissues and organs. Autonomic and sensory peripheral neuropathy is a common feature of this disorder. The pathogenesis of the neuropathy is poorly defined. The aims of this study were to investigate vascular and neural function in the cutaneous microcirculation of AL amyloidosis patients. Seven patients with AL amyloidosis and controls were studied. Acetylcholine and sodium nitroprusside were iontophoresed into the forearm skin. Endothelial, smooth muscle, and C-fiber-mediated cutaneous blood flow (CuBF) were recorded by laser Doppler flowmetry. Endothelial vasodilation in the forearm skin was attenuated in AL amyloidosis patients (p = 0.007). Maximum endothelium-mediated CuBF in the patient group was reduced (p = 0.047). No group differences could be detected in the C-fiber response or smooth muscle vasodilation (p value not significant). Maximum C-fiber and endothelium-independent CuBF did not differ between the two groups (p value not significant). Early in the disease, AL amyloidosis patients present with impaired endothelial function. At this stage, C-fiber and smooth muscle function are still preserved. These data suggest that endothelial abnormalities precede and may contribute to the pathogenesis of the neuropathy associated with AL amyloidosis.

Entities:  

Mesh:

Year:  2003        PMID: 12783418     DOI: 10.1002/ana.10552

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

1.  Repeated systemic thromboembolism in a patient with severe cardiac AL amyloidosis without evidence of atrial fibrillation.

Authors:  Francesco Cappelli; Luigi Padeletti; Manlio Acquafresca; Alberto Moggi Pignone; Federico Perfetto
Journal:  Intern Emerg Med       Date:  2013-05-28       Impact factor: 3.397

2.  Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci.

Authors:  Haruki Koike; Yuichi Kawagashira; Masahiro Iijima; Masahiko Yamamoto; Naoki Hattori; Fumiaki Tanaka; Masaaki Hirayama; Yukio Ando; Shu-ichi Ikeda; Gen Sobue
Journal:  J Neurol       Date:  2008-09-24       Impact factor: 4.849

Review 3.  Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs.

Authors:  Adam Castaño; Brian M Drachman; Daniel Judge; Mathew S Maurer
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

4.  Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor.

Authors:  Arnt V Kristen; Johannes Rinn; Ute Hegenbart; David Lindenmaier; Corina Merkle; Christoph Röcken; Stefan Hardt; Evangelos Giannitsis; Hugo A Katus
Journal:  Clin Res Cardiol       Date:  2014-10-21       Impact factor: 5.460

5.  Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins.

Authors:  Raymond Q Migrino; Seth Truran; David D Gutterman; Daniel A Franco; Megan Bright; Brittany Schlundt; Mitchell Timmons; Angelica Motta; Shane A Phillips; Parameswaran Hari
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-30       Impact factor: 4.733

6.  Patterns of neuropathy and autonomic failure in patients with amyloidosis.

Authors:  Annabel K Wang; Robert D Fealey; Tonette L Gehrking; Phillip A Low
Journal:  Mayo Clin Proc       Date:  2008-11       Impact factor: 7.616

Review 7.  Systemic amyloidoses.

Authors:  Luis M Blancas-Mejía; Marina Ramirez-Alvarado
Journal:  Annu Rev Biochem       Date:  2013-02-28       Impact factor: 23.643

8.  Nanoliposomes protect against AL amyloid light chain protein-induced endothelial injury.

Authors:  Seth Truran; Volkmar Weissig; Marina Ramirez-Alvarado; Daniel A Franco; Camelia Burciu; Joseph Georges; Shishir Murarka; Winter A Okoth; Sara Schwab; Parameswaran Hari; Raymond Q Migrino
Journal:  J Liposome Res       Date:  2013-11-15       Impact factor: 3.648

Review 9.  Amyloid formation in light chain amyloidosis.

Authors:  Marina Ramirez-Alvarado
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

10.  Protective role of clusterin in preserving endothelial function in AL amyloidosis.

Authors:  Daniel A Franco; Seth Truran; Camelia Burciu; David D Gutterman; Anthony Maltagliati; Volkmar Weissig; Parameswaran Hari; Raymond Q Migrino
Journal:  Atherosclerosis       Date:  2012-09-01       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.